{"retracted":false,"update":{"timestamp":1491177600000,"doi":"10.1007/s10549-017-4219-3","type":"correction"},"doi":"10.1007/s10549-017-4191-y","journal":"Breast Cancer Research and Treatment","publisher":"Springer Nature","title":"Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials"}
